CCCIT

The CCCIT

The CCCIT (Center for Clinical Cancer and Immunology Trials) coordinates and conducts all clinical trials of hematological and oncological diseases for the department of internal medicine III of the Salzburg Federal Hospital. Since its foundation, more than 10 years ago, the CCCIT has been established as an international renowned center for clinical trials with about 8.800 patients participating.

Our research activities

CURRENT STUDIES

Studies at the department of internal medicine III in the Salzburg Federal Hospital

The medical study activities of the CCCIT are established in the international top league of clinical cancer research. Thus, we are able to offer adjusted therapies to our patients, depending on their individual disease situation.

337

Studies on solid tumours

227

Studies on haematological diseases

14

Rheumatology studies

18

Studies on infectiology

Studies

Why are clinical trials so important?

#1

Only 2-4% of all cancer patients worldwide are taking part in a clinical trial
CCCIT
2020-07-16T14:39:44+02:00
Only 2-4% of all cancer patients worldwide are taking part in a clinical trial
0
CCCIT

#2

82% of all clinical trials in the USA are only conducted in cancer centers, where the patients have the highest survival rates
CCCIT
2020-07-16T14:40:05+02:00
82% of all clinical trials in the USA are only conducted in cancer centers, where the patients have the highest survival rates
0
CCCIT

#3

The participation in clinical trials fluctuates among Canadian Cancer Care centers by about 10 times.
CCCIT
2020-07-16T14:40:25+02:00
The participation in clinical trials fluctuates among Canadian Cancer Care centers by about 10 times.
0
CCCIT

#4

Studies are almost exclusively conducted in Cancer centers located in bigger cities
CCCIT
2020-07-16T14:40:37+02:00
Studies are almost exclusively conducted in Cancer centers located in bigger cities
0
CCCIT

#5

Many studies in the USA and in the OECD have evidenced, that the availability of new drugs has a substantial impact on the survival rate of cancer patients
CCCIT
2020-07-16T14:40:48+02:00
Many studies in the USA and in the OECD have evidenced, that the availability of new drugs has a substantial impact on the survival rate of cancer patients
0
CCCIT

#6

A fast access to these new drugs is essential
CCCIT
2020-07-16T14:40:58+02:00
A fast access to these new drugs is essential
0
CCCIT

#7

The participation in a clinical trial enables the earliest possible access to the newest drugs, which are increasingly effective.
CCCIT
2020-07-16T14:41:09+02:00
The participation in a clinical trial enables the earliest possible access to the newest drugs, which are increasingly effective.
0
CCCIT

From the consent discussion until the start of the therapy

1

The detailed consent discussion takes place with the doctor and the consent form is filled out by the patient

4

Distribution of study drug after fulfilling all inclusion and exclusion criteria of the study

Examinations are conducted and samples are collected and processed, in compliance with the study guidelines

5

Start of the therapy

Worldwide samples are collected by the reference laboratory

6

Manual data entry of all collected patient information into an online database

1

The detailed consent discussion takes place with the doctor and the consent form is filled out by the patient

Examinations are conducted and samples are collected and processed, in compliance with the study guidelines

Worldwide samples are collected by the reference laboratory

4

Distribution of study drug after fulfilling all inclusion and exclusion criteria of the study

5

Start of the therapy

6

Manual data entry of all collected patient information into an online database

PLEASE DONATE NOW!

Support our initiative to fight cancer!

 

With your donation you make an important contribution to cancer research at the Salzburg Cancer Research Institute (SCRI) at the University Hospital Salzburg.

DONATE NOW
DONATE NOW

ISO certification

We met the challenge of the ISO 9001:2015. Our quality management system has been certified through Quality Austria on the 05.10.2017. Renewal audit for ISO Revision 9001:2015 done by Quality Austria on 05.10.2017.

Do you have a request or any questions?

Feel free to contact us – we will get back back to you as soon as possible.

Contact us